Smiths Group plc

LSE SMIN.L

Smiths Group plc EBITDA for the year ending July 31, 2024: USD 745.60 M

Smiths Group plc EBITDA is USD 745.60 M for the year ending July 31, 2024, a 2.64% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Smiths Group plc EBITDA for the year ending July 31, 2023 was USD 726.43 M, a 107.97% change year over year.
  • Smiths Group plc EBITDA for the year ending July 31, 2022 was USD 349.29 M, a -41.31% change year over year.
  • Smiths Group plc EBITDA for the year ending July 31, 2021 was USD 595.10 M, a 37.07% change year over year.
  • Smiths Group plc EBITDA for the year ending July 31, 2020 was USD 434.16 M, a -22.85% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
LSE: SMIN.L

Smiths Group plc

CEO Mr. Roland Carter
IPO Date July 1, 1988
Location United Kingdom
Headquarters 11-12 St James's Square
Employees 15,750
Sector Industrials
Industries
Description

Smiths Group plc operates as a technology company serving the medical technology, security and defense, general industrial, energy, and space and aerospace markets worldwide. It operates through John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect, and Smiths Medical divisions. The John Crane division offers mechanical seals, seal support systems, hydrodynamic bearings, packing materials, power transmission couplings, and specialized filtration systems. The Smiths Detection division provides sensors and systems that detect and identify explosives, narcotics, weapons, chemical agents, biohazards, and contraband. The Flex-Tek division offers engineered components that heat and move fluids and gases for the aerospace, medical, industrial, construction, and domestic appliance markets. The Smiths Interconnect division provides specialized electronic and radio frequency board-level and waveguide devices, connectors, cables, test sockets, and sub-systems for applications in the security and defense, medical, general industrial, and space and aerospace markets. The Smiths Medical division offers infusion systems, vascular access, patient airway, and temperature management equipment products; and specialised devices in areas of diagnostic and emergency patient transport. The company was formerly known as Smiths Industries and changed its name to Smiths Group plc in 2000. Smiths Group plc was founded in 1851 and is headquartered in London, the United Kingdom.

Similar companies

JMAT.L

Johnson Matthey Plc

USD 15.91

-0.90%

REL.L

RELX PLC

USD 45.94

0.03%

PSON.L

Pearson plc

USD 15.75

1.67%

SN.L

Smith & Nephew plc

USD 11.94

-0.50%

SDR.L

Schroders plc

USD 3.76

0.09%

StockViz Staff

January 15, 2025

Any question? Send us an email